Biography and Research Information
OverviewAI-generated summary
Ashok Akula's research focuses on the clinical application and impact of high-sensitivity cardiac troponin T (hs-cTnT) testing. His work investigates the use of hs-cTnT for the detection of myocardial injury and risk stratification in various patient populations, including those with COVID-19 and in emergency department settings. Akula has published studies on the rapid exclusion of acute myocardial injury and infarction using a single hs-cTnT measurement, as well as the diagnosis and prognosis of Type 2 Myocardial Infarction. His research also explores the correlation between baseline hs-cTnT concentrations and the risk of acute myocardial infarction, and the integration of artificial intelligence with electrocardiography in cardiac assessment. He has contributed to evaluating risk stratification scores, such as the HEAR score, for emergency department patients.
Metrics
- h-index: 7
- Publications: 25
- Citations: 237
Selected Publications
-
Lack of Change in the Incidence of Unstable Angina after Transition to High-Sensitivity Cardiac Troponin T (2025)
-
Diagnosis of acute myocardial infarction in patients with renal failure using high-sensitivity cardiac troponin T (2024)
-
Diagnosis of acute myocardial infarction in patients with renal failure using high-sensitivity cardiac troponin T (2024)
-
High Baseline High-Sensitivity Cardiac Troponin T Concentrations and Risk of Index Acute Myocardial Infarction (2024)
Collaboration Network
Top Collaborators
- Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community
- High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19
- Rapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States Evaluation
- Major adverse cardiovascular events after diagnosis of myocardial injury and types 1 and 2 myocardial infarction
- Diagnosis and Prognosis of Type 2 Myocardial Infarction Using Objective Evidence of Acute Myocardial Ischemia: A Validation Study
Showing 5 of 19 shared publications
- Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community
- High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19
- Rapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States Evaluation
- Major adverse cardiovascular events after diagnosis of myocardial injury and types 1 and 2 myocardial infarction
- Diagnosis and Prognosis of Type 2 Myocardial Infarction Using Objective Evidence of Acute Myocardial Ischemia: A Validation Study
Showing 5 of 19 shared publications
- Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community
- High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19
- Rapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States Evaluation
- Major adverse cardiovascular events after diagnosis of myocardial injury and types 1 and 2 myocardial infarction
- Diagnosis and Prognosis of Type 2 Myocardial Infarction Using Objective Evidence of Acute Myocardial Ischemia: A Validation Study
Showing 5 of 19 shared publications
- Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community
- High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19
- Rapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States Evaluation
- Major adverse cardiovascular events after diagnosis of myocardial injury and types 1 and 2 myocardial infarction
- Diagnosis and Prognosis of Type 2 Myocardial Infarction Using Objective Evidence of Acute Myocardial Ischemia: A Validation Study
Showing 5 of 17 shared publications
- Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community
- High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19
- Rapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States Evaluation
- Major adverse cardiovascular events after diagnosis of myocardial injury and types 1 and 2 myocardial infarction
- Diagnosis and Prognosis of Type 2 Myocardial Infarction Using Objective Evidence of Acute Myocardial Ischemia: A Validation Study
Showing 5 of 14 shared publications
- Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community
- High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19
- Rapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States Evaluation
- Major adverse cardiovascular events after diagnosis of myocardial injury and types 1 and 2 myocardial infarction
- Diagnosis and Prognosis of Type 2 Myocardial Infarction Using Objective Evidence of Acute Myocardial Ischemia: A Validation Study
Showing 5 of 13 shared publications
- Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community
- High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19
- Rapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States Evaluation
- Major adverse cardiovascular events after diagnosis of myocardial injury and types 1 and 2 myocardial infarction
- Diagnosis and Prognosis of Type 2 Myocardial Infarction Using Objective Evidence of Acute Myocardial Ischemia: A Validation Study
Showing 5 of 13 shared publications
- Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community
- High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19
- Rapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States Evaluation
- Major adverse cardiovascular events after diagnosis of myocardial injury and types 1 and 2 myocardial infarction
- Diagnosis and Prognosis of Type 2 Myocardial Infarction Using Objective Evidence of Acute Myocardial Ischemia: A Validation Study
Showing 5 of 12 shared publications
- Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community
- Rapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States Evaluation
- Major adverse cardiovascular events after diagnosis of myocardial injury and types 1 and 2 myocardial infarction
- Diagnosis and Prognosis of Type 2 Myocardial Infarction Using Objective Evidence of Acute Myocardial Ischemia: A Validation Study
- Diagnosis of acute myocardial infarction in patients with renal failure using high-sensitivity cardiac troponin T
Showing 5 of 12 shared publications
- Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community
- High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19
- Rapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States Evaluation
- Major adverse cardiovascular events after diagnosis of myocardial injury and types 1 and 2 myocardial infarction
- Diagnosis of acute myocardial infarction in patients with renal failure using high-sensitivity cardiac troponin T
Showing 5 of 10 shared publications
- Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community
- Rapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States Evaluation
- Major adverse cardiovascular events after diagnosis of myocardial injury and types 1 and 2 myocardial infarction
- Use of the HEAR Score for 30-Day Risk-Stratification in Emergency Department Patients
- Diagnosis of acute myocardial infarction in patients with renal failure using high-sensitivity cardiac troponin T
Showing 5 of 8 shared publications
- Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community
- Rapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States Evaluation
- Major adverse cardiovascular events after diagnosis of myocardial injury and types 1 and 2 myocardial infarction
- Diagnosis and Prognosis of Type 2 Myocardial Infarction Using Objective Evidence of Acute Myocardial Ischemia: A Validation Study
- Diagnosis of acute myocardial infarction in patients with renal failure using high-sensitivity cardiac troponin T
Showing 5 of 8 shared publications
- Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community
- Rapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States Evaluation
- Major adverse cardiovascular events after diagnosis of myocardial injury and types 1 and 2 myocardial infarction
- Diagnosis of acute myocardial infarction in patients with renal failure using high-sensitivity cardiac troponin T
- CLINICAL IMPACT OF HIGH-SENSITIVITY CARDIAC TROPONIN T IMPLEMENTATION IN A UNITED STATES REGIONAL HEALTHCARE SYSTEM
Showing 5 of 7 shared publications
- Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community
- Rapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States Evaluation
- Major adverse cardiovascular events after diagnosis of myocardial injury and types 1 and 2 myocardial infarction
- Diagnosis of acute myocardial infarction in patients with renal failure using high-sensitivity cardiac troponin T
- CLINICAL IMPACT OF HIGH-SENSITIVITY CARDIAC TROPONIN T IMPLEMENTATION IN A UNITED STATES REGIONAL HEALTHCARE SYSTEM
Showing 5 of 7 shared publications
- Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community
- Rapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States Evaluation
- Major adverse cardiovascular events after diagnosis of myocardial injury and types 1 and 2 myocardial infarction
- Diagnosis of acute myocardial infarction in patients with renal failure using high-sensitivity cardiac troponin T
- CLINICAL IMPACT OF HIGH-SENSITIVITY CARDIAC TROPONIN T IMPLEMENTATION IN A UNITED STATES REGIONAL HEALTHCARE SYSTEM
Showing 5 of 6 shared publications
Similar Researchers
Based on overlapping research topics